| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Former Director | EVP, R&D &Chief Scientific Of +1 more
3 companies
Haqq Christopher is an EVP, R&D &Chief Scientific Of at Atara Biotherapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $4.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2015 | ATRA Atara Biotherapeutics, Inc. | Chief Medical Officer | Sell | 2,500 | $62.94 | $157,353.00 | -0.5% | |
| Jul 1, 2015 | ATRA Atara Biotherapeutics, Inc. | Chief Medical Officer | Sell | 2,500 | $51.68 | $129,196.00 | -0.5% | |
| Jun 15, 2015 | ATRA Atara Biotherapeutics, Inc. | Chief Medical Officer | Sell | 7,500 | $46.42 | $348,116.00 | -1.0% | |
| Jun 1, 2015 | ATRA Atara Biotherapeutics, Inc. | Chief Medical Officer | Sell | 2,500 | $41.47 | $103,664.50 | -0.3% |